The FDA's sentinel initiative—A comprehensive approach to medical product surveillance
Top Cited Papers
- 14 December 2015
- journal article
- perspectives
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 99 (3), 265-268
- https://doi.org/10.1002/cpt.320
Abstract
In May 2008, the Department of Health and Human Services announced the launch of the Sentinel Initiative by the US Food and Drug Administration (FDA) to create the Sentinel System, a national electronic system for medical product safety surveillance. 1, 2 This system complements existing FDA surveillance capabilities that track adverse events reported after the use of FDA regulated products by allowing the FDA to proactively assess the safety of these products.Keywords
This publication has 5 references indexed in Scilit:
- Electronic Health Data for Postmarket Surveillance: A Vision Not RealizedDrug Safety, 2015
- Mini-Sentinel and Regulatory Science — Big Data Rendered Fit and FunctionalThe New England Journal of Medicine, 2014
- The Food and Drug Administration's Post‐Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprisePharmacoepidemiology and Drug Safety, 2012
- Developing the Sentinel System — A National Resource for Evidence DevelopmentThe New England Journal of Medicine, 2011
- The New Sentinel Network — Improving the Evidence of Medical-Product SafetyThe New England Journal of Medicine, 2009